"These results demonstrate the power of metabolic imaging with FDG PET/CT when staging esophageal cancer," Barber noted. "Our results demonstrate that this technique should be incorporated into routine clinical practice."
Authors of the article "18F-FDG PET/CT Has a High Impact on Patient Management and Provides Powerful Prognostic Stratification in the Primary Staging of Esophageal Cancer: A Prospective Study with Mature Survival Data" include Thomas Barber and Elizabeth Drummond, Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Rodney J. Hicks, Centre for Cancer Imaging, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Cuong P. Duong, Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Trevor Leong, Department of Radiation Oncology, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; and Mathias Bressel, Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Ad Statistics
Times Displayed: 22160
Times Visited: 440 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
Please visit the SNM Newsroom to view the PDF of the study, including images, and further reading about molecular imaging and personalized medicine. To schedule an interview with the researchers, please contact Susan Martonik at (703) 652-6773 or smartonik@snm.org. Current and past issues of The Journal of Nuclear Medicine can be found online at http://jnm.snmjournals.org.
###
About SNM-Advancing Molecular Imaging and Therapy
SNM is an international scientific and medical organization dedicated to raising public awareness about what molecular imaging is and how it can help provide patients with the best health care possible. SNM members specialize in molecular imaging, a vital element of today's medical practice that adds an additional dimension to diagnosis, changing the way common and devastating diseases are understood and treated.
SNM's more than 17,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snm.org.
Back to HCB News
